40
Participants
Start Date
October 19, 2023
Primary Completion Date
August 30, 2025
Study Completion Date
August 30, 2027
AUR108
3 Days dosing, and 4 days no dose in a week
RECRUITING
All India Institute of Medical Sciences, Delhi
RECRUITING
Rajiv Gandhi Cancer Institute and Research Centre, Delhi
RECRUITING
Post Graduate Institute of Medical Education & Research,, Chandigarh
RECRUITING
Super Specialty Hospital (G.M.C) Srinagar, Srinagar
RECRUITING
HCC Happiness Care and Cure Multispeciality Hospital, Ahmedabad
RECRUITING
Unique Hospital, Surat
RECRUITING
Kiran Multi Speciality Hospital, Surat
RECRUITING
Mumbai Onco Care Centre, Mumbai
RECRUITING
Deenanath Mangeshkar Hospital & Research Center, Pune
RECRUITING
MTES Sanjeevan Hospital, Pune
RECRUITING
Kolhapur Cancer Centre, Kolhāpur
RECRUITING
HCG Manavata Cancer Centre, Nashik
RECRUITING
All India Institute of Medical Sciences, Nagpur
RECRUITING
Sujan Surgical Cancer Hospital and Amravati Cancer Foundation, Amravati
RECRUITING
MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad
RECRUITING
Omega Cancer Hospitals, Visakhapatnam
RECRUITING
KLES Dr Prabhakar Kore Hospital and MRC, Belagavi
RECRUITING
Amrita Institute of Medical Sciences (AIMS), Kochi
RECRUITING
Tata Medical Center, Kolkata
RECRUITING
Sparsh Hospital and Critical Care (P) Ltd., Bhubaneswar
Lead Sponsor
Aurigene Discovery Technologies Limited
INDUSTRY